 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
A Phase I/II Study of the Photon Radiosurgery System
|
|
|
|
Phase II, Phase I
|
|
|
|
CNS 0201
NCT00179907
|
|
| |
ZD6474 in Treating Patients With Recurrent or Progressive Gliomas
|
|
|
|
Phase II, Phase I
|
|
|
|
NCI-06-C-0063
NCI-P6680, NCT00293566
|
|
| |
High Dose CPT-11 in Recurrent Unresectable Malignant Glioma
|
|
|
|
Phase II, Phase I
|
|
|
|
1068114
44OE-ONC-0020-3, NCT00283556
|
|
| |
Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors
|
|
|
|
Phase II, Phase I
|
|
|
|
R01 CA 89395-01
Topotecan, Brain Tumors, Intracerebral Clysis, NCT00452959
|
|
| |
Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
|
|
|
|
Phase II, Phase I
|
|
|
|
UCLA-0604104
OSI3781s, NCT00509431
|
|
| |
A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
|
|
|
|
Phase II, Phase I
|
|
|
|
TM601-008
NCT00683761
|
|
| |
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
|
|
|
|
Phase II
|
|
|
|
RTOG-0424
RTOG-0424, NCT00114140
|
|
| |
Temozolomide in Treating Patients With Low-Grade Glioma
|
|
|
|
Phase II
|
|
|
|
UCSF-99102
BTRC-9902, UCSF-H7858-16278-07, NCT00313729
|
|
| |
Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
|
|
|
|
Phase II
|
|
|
|
05-079
NCT00200161
|
|
| |
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
|
|
|
|
Phase II
|
|
|
|
MSKCC-05122
NCT00445965
|
|
